Business Context and Reporting Period
This Form 8-K filing by GERON CORP (GERN) reports on events occurring at the 2026 Annual Meeting of Stockholders held on May 20, 2026. The filing details the results of stockholder votes on director elections, equity plan amendments, executive compensation, and auditor ratification.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. The text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
The following material actions were approved by stockholders at the May 20, 2026 meeting:
- Equity Plan Amendment: Stockholders approved an amendment to the 2018 Equity Incentive Plan, increasing the number of shares issuable under the plan by 4,500,000 shares.
- Director Elections: Three Class III director nominees were elected to three-year terms expiring in 2029:
- Susan M. Molineaux: 355,206,267 votes for; 37,996,712 votes withheld.
- Patricia S. Andrews: 387,194,039 votes for; 6,008,940 votes withheld.
- Constantine Chinoporos: 387,061,554 votes for; 6,141,425 votes withheld.
- Executive Compensation: The non-binding advisory vote to approve named executive officer compensation was approved with 372,129,132 votes for and 19,673,460 votes against.
- Auditor Ratification: Stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with 486,459,028 votes for and 9,474,870 votes against.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, operational outlook, or specific risk factors. The document focuses strictly on the procedural outcomes of the annual meeting.
Investor Verification Checklist
- Verify the full text of the Amended 2018 Equity Incentive Plan (Exhibit 10.1) to understand the specific terms of the 4.5 million share increase.
- Review the 2026 Proxy Statement filed on April 7, 2026, for detailed descriptions of the director nominees and executive compensation rationale.
- Confirm the total number of shares outstanding to assess the dilution impact of the new equity plan shares.
- Monitor future filings for the company's next quarterly or annual report to obtain actual financial performance metrics absent from this 8-K.